Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Schilder's disease is a progressive demyelinating disorder of the central nervous system.
Features include: Cerebral visual impairment and Diffuse cerebral sclerosis.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 2 | Cerebral visual impairment, Diffuse cerebral sclerosis |
Eyes |
Estimated prevalence: Unknown (Unknown prevalence).
1 clinical trial registered. Pipeline includes 1 PHASE1.
3 publications have been identified in PubMed for Schilder disease. Research spans Review / Meta-Analysis (100%).
Vallar G (2025). [PMID: 39245899](https://pubmed.ncbi.nlm.nih.gov/39245899/). *J Neuropsychol*. [Review / Meta-Analysis]
Makharia A (2025). [PMID: 40090289](https://pubmed.ncbi.nlm.nih.gov/40090289/). *J Neuroimmunol*. [Review / Meta-Analysis]
Misu T (2025). [PMID: 40943458](https://pubmed.ncbi.nlm.nih.gov/40943458/). *Int J Mol Sci*. [Review / Meta-Analysis]
Data assembled from 6 of 12 sources · Last updated Sep 19, 2026, 11:53 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about Schilder disease
1
Cerebral visual impairment |